logo

For the Inventor, By the Inventor

Rome, Italy

Giovanna De Luca

This inventor holds 18 USPTO granted patents, primarily in Peptide Pharmaceuticals. Top assignees: Polifarma S.p.a., Eniricerche S.p.a., Enichem Elastomeri S.p.a.. Active years: 1985-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giovanna De Luca. Retrieved from https://idiyas.com/inventor/giovanna-de-luca

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18

% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 8

Forward Citations = 131(Granted Patents)


Location History:

  • Roma RM, IT (1991)
  • Rome, IT (1985 - 2000)

Company Filing History:

goldMedal16 out of 18 
 
Polifarma S.p.a.
 patents
silverMedal3 out of 260 
 
Eniricerche S.p.a.
 patents
bronzeMedal1 out of 16 
 
Enichem Elastomeri S.p.a.
 patents
4. 1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1985-2000

Loading Chart...
Areas of Expertise:
Zinc-Dependent Metalloproteinases
Hypotensive Activity
Tripeptide Compounds
Indolepyruvic Acid
Pharmacological Treatment
Peptido-Mimetic Substances
Uridine
Cosmetic Use
Therapeutic Activity
Decapeptides
Amino Acids
Radical Sequences
18 patents (USPTO):Explore Patents
1. 6057297 - Inhibitor compounds of zinc-dependent metalloproteinases associated with (2000-05-02),
2. 5846755 - Method for determining the therapeutic activity of metalloproteinase (1998-12-08),
3. 5736518 - Peptide compounds of (L) amino acids and ring molecules, and (1998-04-07),
4. 5504071 - Compounds with a sequence of three radicals, the central one being .alpha.- (1996-04-02),
5. 5447951 - Method for reducing the level of glucocorticoids in the blood and (1995-09-05),
6. 5210215 - Tryptophane and 3-indolepyruvic acid, methods of production therefor (1993-05-11),
7. 5190948 - Use of uridine in the pharmacological treatment of the peripheral (1993-03-02),
8. 5143903 - Method of treatment with tripeptide pharmaceutical compositions as (1992-09-01),
9. 5091172 - Cosmetic use of 3-indolepyruvic acid (1992-02-25),
10. 5051404 - Tripeptide compounds having hypotensive activity (1991-09-24),
11. 5002963 - 3-indolepyruvic acid derivatives and pharmaceutical use thereof (1991-03-26),
12. 4960759 - Pharmacological use of uridine in the treatment of nervous disorders (1990-10-02),
13. 4810779 - Decapeptides having hypotensive action and process for their preparation (1989-03-07),
14. 4808728 - Production of indolepyruvic acid and the 5-hydroxy derivative thereof (1989-02-28),
15. 4748155 - Pharmacologically active tripeptides and process for their synthesis (1988-05-31),

Title: Giovanna De Luca: Innovator in Metalloproteinase Research

Introduction

Giovanna De Luca is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of metalloproteinase research, holding a total of 18 patents. Her work focuses on developing innovative compounds that can inhibit zinc-dependent metalloproteinases, which are crucial in various pathological conditions.

Latest Patents

Among her latest patents are the following:

1. Inhibitor compounds of zinc-dependent metalloproteinases associated with peptidomimetic compounds capable of inhibiting zinc-dependent metalloproteinases to treat pathological conditions associated with the activation of endogenous metalloproteinases in mammals.

2. Method for determining the therapeutic activity of metalloproteinase, which outlines a method for determining the therapeutic potential of peptidomimetic compounds as inhibitors of zinc-dependent metalloproteinase activity associated with pathological conditions in humans and animals.

Career Highlights

Giovanna has worked with notable companies such as Polifarma S.p.a. and Eniricerche S.p.a. Her expertise in the field has led to advancements in therapeutic strategies for treating diseases linked to metalloproteinase activity.

Collaborations

Throughout her career, Giovanna has collaborated with esteemed colleagues, including Giovanni Di Stazio and Vincenzo Politi. These partnerships have further enriched her research and innovation in the field.

Conclusion

Giovanna De Luca's contributions to metalloproteinase research exemplify her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a leading inventor in this critical area of study.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…